Biotech

ActivX Biosciences Publishes Two Key Articles Demonstrating Breadth of Applications for KiNativ(R) Technology in Drug Discovery

LA JOLLA, CA: ...

Beleave Announces Adoption of Advance Notice By-Law

TORONTO, ONTARIO: ...

Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV(R) (telavancin), Including Ongoing TOUR(TM) Observational Patient Registry, at IDWeek 2016

DUBLIN, IRELAND: First Presentation of TOUR Data Highlights Real World Experience with VIBATIV in Range of Difficult-to-Treat Infections; Additional VIBATIV Presentations Report Results from Retrospective Analysis in ...

Cannigistics Agri-Solutions Corp. Announces the Launch of the "LEAFHub" Cloud

VANCOUVER, BRITISH COLUMBIA: ...

Atossa Genetics Inc. to Present at Upcoming Investor Conferences in October 2016

SEATTLE, WA: ...

hVIVO to Present at the 2016 BIO Investor Forum

LONDON, UNITED KINGDOM: ...

Beleave Announces Debt Settlement

TORONTO, ONTARIO: ...

Zeptometrix Files Infringement Action Against Microbix

TORONTO, ONTARIO: Company Confident Allegations are Without Merit ...

VBI Vaccines Completes Pre-IND Meeting for its Glioblastoma Immunotherapy Candidate

CAMBRIDGE, MASSACHUSETTS: ...

Positive Preclinical Data for Immunovaccine''s DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe

HALIFAX, NOVA SCOTIA: Collaboration with The University of Edinburgh Examined Vaccine Candidate's Effects on Most Lethal Form of the Parasitic Disease ...